bendroflumethiazide has been researched along with Stroke in 7 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Indapamide (IND) and bendroflumethiazide (BDZ) are both widely used in the management of blood pressure after stroke." | 5.12 | Comparison of the effect of diuretics on carotid blood flow in stroke patients. ( Alem, M; Lees, K; Milia, P; Muir, S; Walters, M, 2006) |
| " Bendrofluazide appears to be an ineffective hypotensive agent at the standard dosage in the initial post-stroke period." | 2.71 | Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period. ( Eames, PJ; Panerai, RB; Potter, JF; Robinson, TG, 2005) |
| "Hypertension is an important risk factor for adverse cardiovascular events including stroke, myocardial infarction, heart failure and renal failure." | 2.55 | Pharmacotherapy for hypertension in adults aged 18 to 59 years. ( Gueyffier, F; Musini, VM; Puil, L; Salzwedel, DM; Wright, JM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musini, VM | 1 |
| Gueyffier, F | 1 |
| Puil, L | 1 |
| Salzwedel, DM | 1 |
| Wright, JM | 1 |
| Macfarlane, TV | 1 |
| Pigazzani, F | 1 |
| Flynn, RWV | 1 |
| MacDonald, TM | 1 |
| Eames, PJ | 2 |
| Robinson, TG | 2 |
| Panerai, RB | 2 |
| Potter, JF | 2 |
| Milia, P | 1 |
| Muir, S | 1 |
| Alem, M | 1 |
| Lees, K | 1 |
| Walters, M | 1 |
| Rahn, KH | 1 |
| Miall, WE | 1 |
3 reviews available for bendroflumethiazide and Stroke
| Article | Year |
|---|---|
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cause of Death; Coronary Diseas | 2017 |
The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.
Topics: Bendroflumethiazide; Blood Pressure; Coronary Artery Disease; Diuretics; Humans; Hypertension; Indap | 2019 |
Beta-blockers vs. thiazides in the treatment of hypertension: a review of the experience of the large national trials.
Topics: Adrenergic beta-Antagonists; Bendroflumethiazide; Clinical Trials as Topic; Coronary Disease; Diuret | 1990 |
3 trials available for bendroflumethiazide and Stroke
| Article | Year |
|---|---|
The systemic haemodynamic and cerebral autoregulatory effects of bendrofluazide in the subacute post-stroke period.
Topics: Adult; Aged; Aged, 80 and over; Bendroflumethiazide; Blood Flow Velocity; Blood Pressure; Cerebrovas | 2004 |
Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Female; Human | 2005 |
Comparison of the effect of diuretics on carotid blood flow in stroke patients.
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Carotid Arteries; Cerebrovascular Circulation; Diu | 2006 |
1 other study available for bendroflumethiazide and Stroke
| Article | Year |
|---|---|
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Cor | 2007 |